Lipika Goyal
MD, MPhil
Associate Professor, Medicine, Gastrointestinal Oncology
👥Biography 个人简介
Lipika Goyal is a GI oncologist specializing in biliary tract cancers and hepatocellular carcinoma, with a focus on combining molecular targeted agents with immune checkpoint inhibitors. She has investigated pembrolizumab plus targeted agents in cholangiocarcinoma and other GI cancers including FGFR2 inhibitors and IDH1 inhibitors in combination with immunotherapy. Her translational research examines the immunologic effects of targeted oncogene inhibition and strategies to enhance immune checkpoint efficacy in GI tumors with low mutational burden. She participates in NCI-sponsored GI cancer trials.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Lipika Goyal 的研究动态
Follow Lipika Goyal's research updates
留下邮箱，当我们发布与 Lipika Goyal（Stanford University School of Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment